Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHERIE JAN RASH

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1780077552
CMS profile
10961852
Location
CLARKSTON, WA

General Payments · PY2021–2024

$683.09

  • Reported across 24 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$507.52

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $408.29 16
Education $99.23 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $27.39 2
PY2023 $148.18 5
PY2024 $507.52 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $27.45 03/28/2024 Food and Beverage Undisputed 01/23/2026 1104544500 CMS
AstraZeneca Pharmaceuticals LP $30.30 05/31/2024 Food and Beverage Undisputed 01/23/2026 1104233081 CMS
AstraZeneca Pharmaceuticals LP $11.80 07/24/2024 Food and Beverage Undisputed 01/23/2026 1104276137 CMS
AstraZeneca Pharmaceuticals LP $24.47 07/25/2024 Food and Beverage Undisputed 01/23/2026 1104300086 CMS
AstraZeneca Pharmaceuticals LP $26.75 08/08/2024 Food and Beverage Undisputed 01/23/2026 1105689437 CMS
AstraZeneca Pharmaceuticals LP $20.66 08/15/2024 Food and Beverage Undisputed 01/23/2026 1104336028 CMS
AstraZeneca Pharmaceuticals LP $22.66 10/24/2024 Food and Beverage Undisputed 01/23/2026 1105485311 CMS
AstraZeneca Pharmaceuticals LP $20.48 10/31/2024 Food and Beverage Undisputed 01/23/2026 1105815631 CMS
BioCryst US Sales Co., LLC $26.78 10/17/2024 Food and Beverage Undisputed 01/23/2026 1117471028 CMS
BioCryst US Sales Co., LLC $47.58 11/21/2024 Food and Beverage Undisputed 01/23/2026 1117471030 CMS
Blueprint Medicines Corporation $29.18 09/12/2024 Food and Beverage Undisputed 01/23/2026 1147445950 CMS
GlaxoSmithKline, LLC. $23.11 05/23/2024 Food and Beverage Undisputed 01/23/2026 1116178115 CMS
GlaxoSmithKline, LLC. $30.14 10/03/2024 Food and Beverage Undisputed 01/23/2026 1116393760 CMS
Grifols USA, LLC $22.22 08/01/2024 Food and Beverage Undisputed 01/23/2026 1124719088 CMS
Regeneron Healthcare Solutions, Inc. $23.28 09/19/2024 Food and Beverage Undisputed 01/23/2026 1114360618 CMS
Regeneron Healthcare Solutions, Inc. $99.23 12/09/2024 Education Undisputed 01/23/2026 1114360620 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.43 01/10/2024 Food and Beverage Undisputed 01/23/2026 1137812072 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.